Our Recent Research News
We have recently provided funding to the Institute of Cancer Research (ICR) to help support their ground-breaking breast cancer research programme. The ICR is one of the world’s most influential research organisations. They are the world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. The ICR relies on support from charities, donors, partner organisations and the general public. It does not receive any government funding. That is why we chose the ICR as the first organisation to receive funding from us.
February 2017: Scientists at the Institute of Cancer Research, London, have created a ‘map’ linking the shape of breast cancer cells to the activation of their genes. This could point towards new treatments and help improve the effectiveness of immunotherapies.
A thousand breast and ovarian cancer patients have now benefited from a faster BRCA gene testing process that was developed in the UK and is being adopted around the globe. The new approach was developed by researchers at the Institute of Cancer Research (ICR) and the pilot was initially started in 2013.
Scientists at the ICR discovered that non-cancer cells that wrap around blood vessels — called ‘pericytes’ — are helping breast cancer cells enter the bloodstream and spread around the body. The study represents an important step forward in researchers’ understanding of how and why breast cancer spreads.
A blood test that detects when the most common form of breast cancer has become resistant to treatment could double the average time it takes for the disease to progress. A new study conducted by ICR scientists shows the average time it takes the disease to progress increasing from around two and a half to around six months. The test detects low levels of cancer DNA in the blood and can spot women who will respond poorly to current hormonal treatments and who are more likely to benefit from newer drugs.
Scientists at the ICR linked two genes to breast cancer survival after analysing the results of a study of almost 2,000 patients. Testing for these genes could highlight women who are at increased risk of dying from their breast cancers.
Breast Cancer Research Aid’s support of the work carried out at The Institute of Cancer Research, London, helps ensure discoveries made in our laboratories lead to new treatments for breast cancer. At the ICR we discover new cancer drugs and combination therapies. We uncover new insights into the causes of breast cancer and how it becomes resistant to treatment, and we develop novel ways to image tumours. But to embark on our innovative research, we need your support. This is where Breast Cancer Research Aid plays such an important role. Through your funding, our scientists are able to continue their research with access to the latest technology and cutting-edge infrastructure. This will allow them to continue making significant steps towards improving the lives of breast cancer patients around the world.
THE INSTITUTE OF CANCER RESEARCH (ICR), LONDON
Thanks to the support of Breast Cancer Research Aid, scientists here at Cardiff University’s European Cancer Stem Cell Research Institute are able to carry out world-leading research which has the potential to revolutionise the way we tackle cancer. By improving our understanding of how and why different cancers grow and spread, we aim to develop new and effective therapies which will make a real difference to the lives of cancer patients - and your support will help us to get there faster.